← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
76	76 Marker Therapeutics MRKR $15.3M	26	-2	-7%	$10.9M
77	77 Pluri PLUR $11.9M	26	-2	-7%	$414K
78	78 Mustang Bio MBIO $2.93M	25	-1	-4%	$1.4M
79	79 Senti Biosciences Holdings SNTI $8.14M	25	0	0%	$7.56M
80	80 BioCardia BCDA $14.2M	24	+8	+50%	$1.37M
81	81 Candel Therapeutics CADL $682M	22	+2	+10%	$5.92M
82	LGVN 82 Longeveron LGVN $4.78M	22	+4	+22%	$3.42M
83	83 DELISTED Scorpius Holdings, Inc. SCPX	22	+4	+22%	$747K
84	84 Calidi Biotherapeutics CLDI $2.25M	21	+11	+110%	$2.83M
85	85 Coya Therapeutics COYA $102M	21	+6	+40%	$20.6M
86	86 Genprex GNPX $1.88M	21	+4	+24%	$1.16M
87	ACHL 87 DELISTED Achilles Therapeutics ACHL	20	+2	+11%	$19.4M
88	88 DELISTED Orgenesis Inc. Common Stock ORGS	19	-1	-5%	$784K
89	89 Imunon IMNN $5.95M	18	+3	+20%	$286K
90	90 Enlivex Ltd ENLV $4.46M	16	+1	+7%	$509K
91	FRLN 91 DELISTED Freeline Therapeutics Holdings plc American Depositary Shares FRLN	15	+3	+25%	$12.4M
92	GRML 92 Greenland Mines Ltd GRML $92.9M	15	-9	-38%	$18.8M
93	93 Benitec Biopharma BNTC $295M	13	+1	+8%	$3.88M
94	94 BioRestorative Therapies BRTX $2.02M	13	+2	+18%	$541K
95	95 enGene Therapeutics ENGN $115M	11	+11	–	$131M
96	96 DELISTED CERo Therapeutics CERO	9	-1	-10%	$7.49M
97	97 Eterna Therapeutics ERNA $2.53M	9	0	0%	$637K
98	98 DELISTED NKGen Biotech, Inc. Common Stock NKGN	9	-4	-31%	$13.7M
99	99 Creative Medical Technology CELZ $6.21M	8	0	0%	$90.4K
100	ATHX 100 DELISTED Athersys, Inc. Common Stock ATHX	7	-36	-84%	$5.51K